Growth Factors, Oncogenes and Tumour Suppressor Genes
Control of cell proliferation involves a complex interplay between direct mechanisms linking a cell with adjacent cells and their interstitial stroma, and indirect mechanisms mediated through factors carried by organ vasculature. Disruption of the functional integrity of growth regulatory systems may lead to uncontrolled proliferation and abnormal cellular behaviour manifest in a most extreme form in the development of malignant tumours.
KeywordsSerum Response Factor SteroId Hormone Human Breast Carcinoma Cell Line Serum Response Element Tumour Suppressor Gene Product
Unable to display preview. Download preview PDF.
- Diller L, Kassel J and Nelson CE, et al. (1990) p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 11:5752–5781Google Scholar
- Dumont JE, Jauniaux JC and Roger PP (1989) The cyclic AMP-mediated stimulation of cell proliferation. TIBS 114:67–70Google Scholar
- Evans G (1990) The myc oncogene. In: Carney D, Sikora K (eds) Genes and cancer. John Wiley amp Sons Ltd, Chichester, pp 31–43Google Scholar
- Karin M (1989) Complexities of gene regulation by cAMP. TIBS 5:65–67Google Scholar
- Ong G, Sikora K and Gullick WJ (1991) Inactivation of the retinoblastoma gene does not lead to loss of TGFβ receptor or loss of response to TGFβ in breast cancer cell lines. Oncogene (in press)Google Scholar
- Rayter SI, Iwata KK, Michitsch RW, Sorvillo JM, Valenzuela DM and Foulkes JG (1989) Biochemical function of oncogenes. In: Glover DM, Hames BD (eds) Oncogenes. Oxford University Press, Oxford, pp 113–189Google Scholar
- Shaw PE, Frasch S and Nordheim A (1989b) Repression of c-fos transcription is mediated through p67SRF bound to the SRE. EMBO J 8:2567–2574Google Scholar